Patents by Inventor Balasingam Radhakrishnan

Balasingam Radhakrishnan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11819533
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: November 21, 2023
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Bartizal, Paul Daruwala, David Hughes, Martin Patrick Hughes, Navdeep B. Malkar, Balasingam Radhakrishnan, Anuradha Vaidya
  • Publication number: 20230365629
    Abstract: The present invention relates to echinocandin cyclopeptides and to methods for preparing echinocandin cyclopeptides.
    Type: Application
    Filed: December 8, 2022
    Publication date: November 16, 2023
    Inventors: David HUGHES, Martin Patrick HUGHES, Balasingam RADHAKRISHNAN, Robert Michael HUGHES, Yannick BORGUET, Steven MCINTYRE
  • Patent number: 11654196
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: May 23, 2023
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Patent number: 11524980
    Abstract: The present invention relates to echinocandin cyclopeptides and to methods for preparing echinocandin cyclopeptides.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: December 13, 2022
    Assignee: Cidara Therapeutics, Inc.
    Inventors: David Hughes, Martin Patrick Hughes, Robert Michael Hughes, Balasingam Radhakrishnan, Yannick Borguet, Steven McIntyre
  • Publication number: 20220323539
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Application
    Filed: December 1, 2021
    Publication date: October 13, 2022
    Inventors: Kenneth BARTIZAL, Paul DARUWALA, David HUGHES, Martin Patrick HUGHES, Navdeep B. MALKAR, Balasingam RADHAKRISHNAN, Anuradha VAIDYA
  • Publication number: 20220287996
    Abstract: The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
    Type: Application
    Filed: February 25, 2022
    Publication date: September 15, 2022
    Inventors: Balasingam RADHAKRISHNAN, Ben ESQUE, Wei LIN, Andrew Xian CHEN
  • Publication number: 20220162263
    Abstract: The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.
    Type: Application
    Filed: July 1, 2021
    Publication date: May 26, 2022
    Inventors: Kenneth Duke JAMES, JR., Christopher Patrick LAUDEMAN, Navdeep Balkrishna MALKAR, Balasingam RADHAKRISHNAN
  • Patent number: 11260038
    Abstract: The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: March 1, 2022
    Assignee: RESQ Pharmaceuticals LLC
    Inventors: Balasingam Radhakrishnan, Ben Esque, Wei Lin, Andrew Xian Chen
  • Patent number: 11197909
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: December 14, 2021
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Bartizal, Paul Daruwala, David Hughes, Martin Patrick Hughes, Navdeep B. Malkar, Balasingam Radhakrishnan, Anuradha Vaidya
  • Patent number: 11123319
    Abstract: The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: September 21, 2021
    Assignee: RESQ Pharmaceuticals LLC
    Inventors: Balasingam Radhakrishnan, Ben Esque, Wei Lin, Andrew Xian Chen
  • Publication number: 20210179667
    Abstract: The present invention relates to echinocandin cyclopeptides and to methods for preparing echinocandin cyclopeptides.
    Type: Application
    Filed: June 14, 2019
    Publication date: June 17, 2021
    Inventors: David HUGHES, Martin Patrick HUGHES, Robert Michael HUGHES, Balasingam RADHAKRISHNAN, Yannick BORGUET, Steven MCINTYRE
  • Publication number: 20210169833
    Abstract: The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
    Type: Application
    Filed: December 4, 2020
    Publication date: June 10, 2021
    Inventors: Balasingam RADHAKRISHNAN, Ben ESQUE, Wei LIN, Andrew Xian CHEN
  • Publication number: 20210128670
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Application
    Filed: July 2, 2020
    Publication date: May 6, 2021
    Inventors: Balasingam RADHAKRISHNAN, Kenneth Duke JAMES, JR., Anuradha VAIDYA, Karen POLOWY
  • Publication number: 20200268833
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Application
    Filed: July 11, 2018
    Publication date: August 27, 2020
    Inventors: Kenneth BARTIZAL, Paul DARUWALA, David HUGHES, Martin Patrick HUGHES, Navdeep B. MALKAR, Balasingam RADHAKRISHNAN, Anuradha VAIDYA
  • Patent number: 10702573
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: June 25, 2018
    Date of Patent: July 7, 2020
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Publication number: 20190160141
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Application
    Filed: June 25, 2018
    Publication date: May 30, 2019
    Inventors: Balasingam RADHAKRISHNAN, Kenneth Duke JAMES, JR., Anuradha VAIDYA, Karen POLOWY
  • Patent number: 10016479
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: July 10, 2018
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Publication number: 20170253635
    Abstract: The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.
    Type: Application
    Filed: May 18, 2017
    Publication date: September 7, 2017
    Inventors: Kenneth Duke JAMES, JR., Christopher Patrick LAUDEMAN, Navdeep Balkrishna MALKAR, Balasingam RADHAKRISHNAN
  • Patent number: 9676821
    Abstract: The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: June 13, 2017
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Duke James, Jr., Christopher Patrick Laudeman, Navdeep Balkrishna Malkar, Balasingam Radhakrishnan
  • Publication number: 20170151306
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Application
    Filed: December 7, 2016
    Publication date: June 1, 2017
    Inventors: Balasingam RADHAKRISHNAN, Kenneth Duke JAMES, JR., Anuradha VAIDYA, Karen POLOWY